![]() |
市場調查報告書
商品編碼
2101620
多種運動科技:市場機會、成長要素、產業趨勢分析及2026-2035年預測Haploid Induction Technology for Seed Breeding Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026 - 2035 |
||||||
預計到 2025 年,全球倍增器運動技術市場價值將達到 4.6 億美元,並以 10.1% 的複合年成長率成長,到 2035 年將達到 12 億美元。

隨著種子研發者擴大採用先進的育種技術來加速作物改良並提高遺傳精準度,單倍體種子技術市場正在迅速發展。 CRISPR/Cas9基因編輯技術與二倍體-單倍體(DH)平台的結合,透過加速精準改良自交系的開發,正成為重要的成長機會。這些整合技術有助於縮短傳統育種週期,並為大規模性狀開發創造新的機會。種子企業越來越傾向將DH系建構外包給專業服務供應商,這也對市場產生了正面影響。這使得企業能夠減少基礎設施投資並提高營運效率。單倍體誘導方法的應用範圍正在從傳統領域擴展到更廣泛的作物,人們對其的興趣日益濃厚。育種方案的進步正在為各種作物類別和地區開闢新的機遇,從而支持更廣泛的商業性應用。技術的擴展正在強化單倍體誘導系統作為現代種子開發和精密農業中重要工具的作用。
| 市場範圍 | |
|---|---|
| 開始年份 | 2025 |
| 預測期 | 2026-2035 |
| 初始市場規模 | 4.6億美元 |
| 預測金額 | 12億美元 |
| 複合年成長率 | 10.1% |
預計到2025年,體內單倍體誘導技術的市場規模將達到1.919億美元,並在2026年至2035年間以8.6%的複合年成長率成長。由於該技術在商業性育種項目中得到廣泛應用,因此在種子育種市場的單倍體誘導技術領域中保持主導地位。此方法具有諸多優勢,例如流程成熟、產業經驗豐富,以及能夠有效率地融入種子研發流程。其擴充性和成本優勢持續支撐著市場穩定的需求,尤其是在尋求快速開發改良作物品種的商業種子生產商中。
預計到2025年,DH系培育市場規模將達到2.899億美元,並在2026年至2035年間以8.8%的複合年成長率成長。此應用領域是單倍體誘導技術在商業和科研育種專案中的核心應用案例。 DH系培育能夠利用多樣化的遺傳資源,生成高度均一的自交系,同時與傳統育種方法相比,能大幅減少所需的時間和資源。這項技術是多種作物雜交種子培育計畫的基礎,由於其能夠提高育種效率和加速遺傳改良進程,其重要性日益凸顯。
預計到2025年,北美多倍體種子技術市場規模將達到1.52億美元。北美憑藉其先進的農業研究體系、強大的商業種子產業以及二倍體單倍體育種技術的廣泛應用,在全球多倍體種子技術產業中處於主導地位。該地區受益於對作物遺傳學、生物技術研究和先進育種基礎設施的大量投資。在美國營運的領先種子企業正不斷將二倍體單倍體技術融入其育種流程,這將促進其商業性應用並增強區域市場成長。
全球多倍體種子技術市場的主要參與者包括先正達公司 (Syngenta AG)、科迪華農業科技公司 (Corteva Agriscience)、拜耳作物科學公司 (Bayer Crop Science)、巴斯夫公司 ( BASF SE,位於紐恩海姆斯)、利馬格蘭公司 (Limagrain)、KWS SAAT SE & Co. KK、kijk Corporation (Sijak Corporation) Zwaan)、菲塔戈拉斯公司 (Fytagoras)、ScreenSYS公司、Haplotech公司、國際玉米小麥改良中心 (CIMMYT)、愛荷華州立大學雙單倍體 (DH) 設施、霍恩海姆大學雙單倍體計畫以及羅馬尼亞的Procera公司。這些公司正透過合作研究、技術開發和拓展其先進育種能力來鞏固其市場地位。產業相關人員正致力於投資創新育種平台、提高雙單倍體 (DH) 生產效率以及整合基因編輯技術以最佳化作物開發流程。此外,各公司也與研究機構合作,並拓展服務範圍,以支援種子開發者更廣泛地採用這些技術。透過增加對自動化、先進遺傳工具和專業育種服務的投資,各公司正在提高擴充性並縮短開發週期。
The Global Haploid Induction Technology for Seed Breeding Market was valued at USD 460 million in 2025 and is estimated to grow at a CAGR of 10.1% to reach USD 1.2 billion by 2035.

The haploid induction technology for seed breeding market is advancing rapidly as seed developers increasingly adopt advanced breeding approaches to accelerate crop improvement and enhance genetic precision. The combination of CRISPR/Cas9 gene editing with doubled haploid (DH) platforms is emerging as a significant growth opportunity by enabling faster development of precisely improved inbred lines. These integrated technologies are helping reduce traditional breeding timelines while creating new opportunities for large-scale trait development. The market is also benefiting from the growing preference among seed companies to outsource DH line generation to specialized service providers, allowing them to reduce infrastructure investments and improve operational efficiency. Adoption of haploid induction methods is expanding beyond traditional applications, with increasing interest across a wider range of crops. Advances in breeding protocols are helping unlock new opportunities across different crop categories and regions, supporting broader commercial adoption. The expansion of these technologies is strengthening the role of haploid induction systems as a valuable tool for modern seed development and precision agriculture.
| Market Scope | |
|---|---|
| Start Year | 2025 |
| Forecast Year | 2026-2035 |
| Start Value | $460 Million |
| Forecast Value | $1.2 Billion |
| CAGR | 10.1% |
The in vivo haploid induction segment was valued at USD 191.9 million in 2025 and is projected to grow at a CAGR of 8.6% between 2026 and 2035. This segment maintains a leading position in the haploid induction technology for seed breeding market due to its strong adoption in commercial breeding programs. The approach benefits from established procedures, extensive industry experience, and efficient integration into seed research and development operations. Its scalability and cost advantages continue to support consistent demand, particularly among commercial seed producers seeking faster development of improved crop varieties.
The DH line development segment accounted for USD 289.9 million in 2025 and is expected to grow at a CAGR of 8.8% from 2026 to 2035. This application area represents the core use case of haploid induction technology across commercial and research-based breeding programs. DH line development enables the generation of highly uniform inbred lines from diverse genetic material while reducing the time and resources required compared with conventional breeding approaches. The technology supports hybrid seed development programs across multiple crops and continues to gain importance due to its ability to improve breeding efficiency and accelerate genetic advancement.
North America Haploid Induction Technology for Seed Breeding Market was valued at USD 152 million in 2025. North America represents a leading region in the global haploid induction technology for seed breeding industry due to its advanced agricultural research ecosystem, strong commercial seed sector, and extensive adoption of doubled haploid methods. The region benefits from significant investments in crop genetics, biotechnology research, and advanced breeding infrastructure. Major seed companies operating in the United States continue to integrate DH technologies into their breeding pipelines, supporting the expansion of commercial applications and strengthening regional market growth.
The major companies operating in the global haploid induction technology for seed breeding market include Syngenta AG, Corteva Agriscience, Bayer Crop Science, BASF SE (Nunhems), Limagrain, KWS SAAT SE & Co. KGaA, Sakata Seed Corporation, Rijk Zwaan, Fytagoras, ScreenSYS, Haplotech Inc., CIMMYT, Iowa State University DH Facility, University of Hohenheim DH Program, and Procera (Romania). Companies operating in the haploid induction technology for seed breeding market are strengthening their market position through research collaborations, technology development, and expansion of advanced breeding capabilities. Industry participants are investing in innovative breeding platforms, improving DH production efficiency, and integrating gene-editing technologies to enhance crop development processes. Companies are also forming partnerships with research institutions and expanding service offerings to support wider adoption among seed developers. Increasing investments in automation, advanced genetic tools, and specialized breeding services are helping businesses improve scalability and reduce development timelines.